Eva Řezníčková

How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?

Radek Jorda, Denisa Hendrychová, Jiří Voller et al. · Journal of Medicinal Chemistry · 2018 · 96 citations · Full text

A Novel Series of Highly Potent 2,6,9-Trisubstituted Purine Cyclin-Dependent Kinase Inhibitors

Tomáš Gucký, Radek Jorda, Marek Zatloukal et al. · Journal of Medicinal Chemistry · 2013 · 49 citations · Full text

Chemoprevention Strategy, Pharmacotherapy, Pharmaceutical Chemistry +16

Discovery of <i>N</i>²-(4-Amino-cyclohexyl)-9-cyclopentyl-<i>N</i>⁶-(4-morpholin-4-ylmethyl-phenyl)-<i>9H</i>-purine-2,6-diamine as a Potent FLT3 Kinase Inhibitor for Acute Myeloid Leukemia with FLT3 Mutations

Tomáš Gucký, Eva Řezníčková, Tereza Radošová Muchová et al. · Journal of Medicinal Chemistry · 2018 · 42 citations · Full text

Molecular Biology, Cell Death, Flt3 Mutations +18

Synthesis and in vitro biological evaluation of 2,6,9-trisubstituted purines targeting multiple cyclin-dependent kinases

Marek Zatloukal, Radek Jorda, Tomáš Gucký et al. · European Journal of Medicinal Chemistry · 2012 · 41 citations · Full text

2,6,9-Trisubstituted Purines, Medicine, Cellular Pharmacology +6

Substituted 2-hydroxy-N-(arylalkyl)benzamides induce apoptosis in cancer cell lines

Aleš Imramovský, Radek Jorda, Karel Pauk et al. · European Journal of Medicinal Chemistry · 2013 · 31 citations

Medicine, Induce Apoptosis, Cell Death +2